March 20th 2023
It affects strawberry products that were sold at Costco and Trader Joe’s.
Biden Administration, Others Working Towards Eliminating Hepatitis CMarch 13th 2023
In the White House’s new budget they have put aside several billion dollars towards establishing a hepatitis C (HCV) program. In addition, an HCV vaccine is expected to go into phase 1 clinical trials this year, and a pharmaceutical company is working with states to gain better therapeutic access.
Hepatitis B Vaccine Authorized in Great BritainMarch 7th 2023
The hepatitis B vaccine (Recombinant), Adjuvanted (Heplisav-B) is approved in adults 18 years of age and older, and the vaccine’s developer, Dynavax, is working towards finding potential commercial partners for Great Britain.
Hepatitis B Prevention: We Have the Vaccines, But Not the ImplementationFebruary 22nd 2023
Despite effective vaccines and other prevention and treatment modalities, hepatitis B remains a global health challenge. “It’s not for the lack of available tools,” says professor and hepatologist H. Nina Kim, MD, MSc.
Conversations Around Diagnosing HIV, Shaping Treatment ExpectationsFebruary 20th 2023
A clinician offers insights on the initial conversations around learning to treat a chronic disease and the importance behind getting patients started down the right treatment path in the early days following a diagnosis.
HBV Infection Linked to Threefold Increase in Fibrosis in Patients with Liver DiseaseFebruary 17th 2023
A recent study suggests that metabolic factors such as hypertension and diabetes were associated with an increased risk of liver fibrosis among patients with metabolic associated fatty liver disease who had hepatitis B virus infection.